Literature DB >> 24244018

Cutting edge: The signals for the generation of T cell memory are qualitatively different depending on TCR ligand strength.

Karin M Knudson1, Sara E Hamilton, Mark A Daniels, Stephen C Jameson, Emma Teixeiro.   

Abstract

CD8 T cell memory critically contributes to long-term immunity. Both low- and high-affinity TCR signals are able to support the differentiation of memory CD8 T cells. However, it is unclear whether the requirements for memory development change when TCR signal strength is altered. To gain further insight into this question, we used a TCRβ transmembrane domain mutant model that is defective in the generation of memory in response to high-affinity ligands. Surprisingly, lowering TCR signal strength, by stimulation with low-affinity ligands, resulted in normal memory development. Restoration of memory correlated with recovery of TCR-dependent NF-κB signaling. Thus, these data provide novel evidence that the requirements for memory are qualitatively different depending on TCR signal strength.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24244018      PMCID: PMC9037717          DOI: 10.4049/jimmunol.1300905

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.426


  31 in total

1.  Thymic selection threshold defined by compartmentalization of Ras/MAPK signalling.

Authors:  Mark A Daniels; Emma Teixeiro; Jason Gill; Barbara Hausmann; Dominique Roubaty; Kaisa Holmberg; Guy Werlen; Georg A Holländer; Nicholas R J Gascoigne; Ed Palmer
Journal:  Nature       Date:  2006-11-01       Impact factor: 49.962

2.  Heterogeneous differentiation patterns of individual CD8+ T cells.

Authors:  Carmen Gerlach; Jan C Rohr; Leïla Perié; Nienke van Rooij; Jeroen W J van Heijst; Arno Velds; Jos Urbanus; Shalin H Naik; Heinz Jacobs; Joost B Beltman; Rob J de Boer; Ton N M Schumacher
Journal:  Science       Date:  2013-03-14       Impact factor: 47.728

Review 3.  T cell recognition of weak ligands: roles of signaling, receptor number, and affinity.

Authors:  Lindsay J Edwards; Brian D Evavold
Journal:  Immunol Res       Date:  2011-05       Impact factor: 2.829

4.  Listeriolysin O-deficient Listeria monocytogenes as a vaccine delivery vehicle: antigen-specific CD8 T cell priming and protective immunity.

Authors:  Sara E Hamilton; Vladimir P Badovinac; Aaruni Khanolkar; John T Harty
Journal:  J Immunol       Date:  2006-09-15       Impact factor: 5.422

5.  T cell division and death are segregated by mutation of TCRbeta chain constant domains.

Authors:  Emma Teixeiro; Mark A Daniels; Barbara Hausmann; Adam G Schrum; Dieter Naeher; Immanuel Luescher; Margot Thome; Rafael Bragado; Ed Palmer
Journal:  Immunity       Date:  2004-10       Impact factor: 31.745

6.  Attenuated T cell responses to a high-potency ligand in vivo.

Authors:  Emily Corse; Rachel A Gottschalk; Michelle Krogsgaard; James P Allison
Journal:  PLoS Biol       Date:  2010-09-14       Impact factor: 8.029

Review 7.  A new look at T cell receptor signaling to nuclear factor-κB.

Authors:  Suman Paul; Brian C Schaefer
Journal:  Trends Immunol       Date:  2013-03-07       Impact factor: 16.687

Review 8.  Homeostasis of naive and memory T cells.

Authors:  Charles D Surh; Jonathan Sprent
Journal:  Immunity       Date:  2008-12-19       Impact factor: 31.745

9.  Low-affinity ligands for the TCR drive proliferation of mature CD8+ T cells in lymphopenic hosts.

Authors:  A W Goldrath; M J Bevan
Journal:  Immunity       Date:  1999-08       Impact factor: 31.745

10.  Complete but curtailed T-cell response to very low-affinity antigen.

Authors:  Dietmar Zehn; Sarah Y Lee; Michael J Bevan
Journal:  Nature       Date:  2009-01-28       Impact factor: 49.962

View more
  13 in total

Review 1.  Innate memory T cells.

Authors:  Stephen C Jameson; You Jeong Lee; Kristin A Hogquist
Journal:  Adv Immunol       Date:  2015-02-07       Impact factor: 3.543

2.  NFκB-Pim-1-Eomesodermin axis is critical for maintaining CD8 T-cell memory quality.

Authors:  Karin M Knudson; Curtis J Pritzl; Vikas Saxena; Amnon Altman; Mark A Daniels; Emma Teixeiro
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-13       Impact factor: 11.205

Review 3.  T-cell receptor affinity in the age of cancer immunotherapy.

Authors:  Michele M Hoffmann; Jill E Slansky
Journal:  Mol Carcinog       Date:  2020-05-09       Impact factor: 4.784

4.  Innate and virtual memory T cells in man.

Authors:  Luc Van Kaer
Journal:  Eur J Immunol       Date:  2015-06-09       Impact factor: 5.532

Review 5.  The perception and response of T cells to a changing environment are based on the law of initial value.

Authors:  Eric S Huseby; Emma Teixeiro
Journal:  Sci Signal       Date:  2022-05-31       Impact factor: 9.517

6.  Altered Binding of Tumor Antigenic Peptides to MHC Class I Affects CD8+ T Cell-Effector Responses.

Authors:  Michael E Birnbaum; Stephanie K Dougan; Eleanor Clancy-Thompson; Christine A Devlin; Paul M Tyler; Mariah M Servos; Lestat R Ali; Katherine S Ventre; M Aladdin Bhuiyan; Patrick T Bruck
Journal:  Cancer Immunol Res       Date:  2018-10-23       Impact factor: 11.151

7.  T cell-NF-κB activation is required for tumor control in vivo.

Authors:  Sarah E Barnes; Ying Wang; Luqiu Chen; Luciana L Molinero; Thomas F Gajewski; Cesar Evaristo; Maria-Luisa Alegre
Journal:  J Immunother Cancer       Date:  2015-01-20       Impact factor: 13.751

8.  The tyrosine kinase Itk suppresses CD8+ memory T cell development in response to bacterial infection.

Authors:  Fei Huang; Weishan Huang; Jessica Briggs; Tina Chew; Yuting Bai; Simrita Deol; Avery August
Journal:  Sci Rep       Date:  2015-01-08       Impact factor: 4.379

Review 9.  TCR Signaling in T Cell Memory.

Authors:  Mark A Daniels; Emma Teixeiro
Journal:  Front Immunol       Date:  2015-12-10       Impact factor: 7.561

Review 10.  Interplay of Inflammatory, Antigen and Tissue-Derived Signals in the Development of Resident CD8 Memory T Cells.

Authors:  Curtis J Pritzl; Mark A Daniels; Emma Teixeiro
Journal:  Front Immunol       Date:  2021-06-21       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.